Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?

Miller ME, Muhsen S, Olcese C, Patil S, Morrow M, Van Zee KJ.

Ann Surg Oncol. 2017 Oct;24(10):2889-2897. doi: 10.1245/s10434-017-5931-2. Epub 2017 Aug 1.

PMID:
28766208
2.

Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore.

Tan ML, Idris DB, Teo LW, Loh SY, Seow GC, Chia YY, Tin AS.

Asia Pac J Oncol Nurs. 2014 Apr-Jun;1(1):22-32.

3.

Trends in Health-Related Quality of Life After a Diagnosis of Ductal Carcinoma In Situ.

Hart V, Sprague BL, Lakoski SG, Hampton JM, Newcomb PA, Gangnon RE, Trentham-Dietz A.

J Clin Oncol. 2016 Apr 20;34(12):1323-9. doi: 10.1200/JCO.2015.62.7281. Epub 2016 Feb 16. Erratum in: J Clin Oncol. 2016 Aug 20;34(24):2943.

4.

Risk perception and psychological morbidity in men at elevated risk for prostate cancer.

Matthew AG, Davidson T, Ochs S, Currie KL, Petrella A, Finelli A.

Curr Oncol. 2015 Dec;22(6):e462-9. doi: 10.3747/co.22.2679.

5.

Partnership Status and Socioeconomic Factors in Relation to Health Behavior Changes after a Diagnosis of Ductal Carcinoma In Situ.

Khadanga S, Lakoski SG, Hart V, Sprague BL, Ba Y, Hampton JM, Higgins ST, Ades PA, Newcomb PA, Trentham-Dietz A.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):76-82. doi: 10.1158/1055-9965.EPI-15-0726. Epub 2015 Nov 6.

6.

Health behavior change following a diagnosis of ductal carcinoma in situ: An opportunity to improve health outcomes.

Berkman AM, Trentham-Dietz A, Dittus K, Hart V, Vatovec CM, King JG, James TA, Lakoski SG, Sprague BL.

Prev Med. 2015 Nov;80:53-9. doi: 10.1016/j.ypmed.2015.03.020. Epub 2015 Apr 6.

7.

Impact of Prophylactic Mastectomy in BRCA1/2 Mutation Carriers.

Rhiem K, Schmutzler R.

Breast Care (Basel). 2014 Dec;9(6):385-9. doi: 10.1159/000369592. Review.

8.

Establishing a program for individuals at high risk for breast cancer.

Cadiz F, Kuerer HM, Puga J, Camacho J, Cunill E, Arun B.

J Cancer. 2013 Jul 1;4(5):433-46. doi: 10.7150/jca.6481. Print 2013.

9.

A phoenix rising: who considers herself a "survivor" after a diagnosis of breast cancer?

Jagielski CH, Hawley ST, Corbin K, Weiss MC, Griggs JJ.

J Cancer Surviv. 2012 Dec;6(4):451-7. doi: 10.1007/s11764-012-0240-z. Epub 2012 Aug 31.

10.

Childhood adversity increases vulnerability for behavioral symptoms and immune dysregulation in women with breast cancer.

Witek Janusek L, Tell D, Albuquerque K, Mathews HL.

Brain Behav Immun. 2013 Mar;30 Suppl:S149-62. doi: 10.1016/j.bbi.2012.05.014. Epub 2012 Jun 1.

11.

Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop.

Partridge AH, Elmore JG, Saslow D, McCaskill-Stevens W, Schnitt SJ.

CA Cancer J Clin. 2012 May-Jun;62(3):203-10. doi: 10.3322/caac.21140. Epub 2012 Apr 4.

12.

Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer.

Liu Y, Pérez M, Schootman M, Aft RL, Gillanders WE, Jeffe DB.

Breast Cancer Res Treat. 2011 Nov;130(1):165-73. doi: 10.1007/s10549-011-1551-x. Epub 2011 May 8.

13.

Status of Intraductal Therapy for Ductal Carcinoma in Situ.

Flanagan M, Love S, Hwang ES.

Curr Breast Cancer Rep. 2010 Jun;2(2):75-82. Epub 2010 May 6.

14.

Quality-of-life issues in patients with ductal carcinoma in situ.

Ganz PA.

J Natl Cancer Inst Monogr. 2010;2010(41):218-22. doi: 10.1093/jncimonographs/lgq029. Review.

15.

Communication between patients and providers and informed decision making.

Elmore JG, Ganschow PS, Geller BM.

J Natl Cancer Inst Monogr. 2010;2010(41):204-9. doi: 10.1093/jncimonographs/lgq038. Review.

16.

Evaluation of psychosocial distress in patients treated in a community-based oncology group practice in Germany.

Mergenthaler U, Heymanns J, Köppler H, Thomalla J, van Roye C, Schenk J, Weide R.

Ann Oncol. 2011 Apr;22(4):931-8. doi: 10.1093/annonc/mdq455. Epub 2010 Oct 6.

17.

Perceived risk for cancer in an urban sexual minority.

Burkhalter JE, Hay JL, Coups E, Warren B, Li Y, Ostroff JS.

J Behav Med. 2011 Jun;34(3):157-69. doi: 10.1007/s10865-010-9296-2. Epub 2010 Sep 25.

18.

A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer.

Liu Y, Pérez M, Schootman M, Aft RL, Gillanders WE, Ellis MJ, Jeffe DB.

Breast Cancer Res Treat. 2010 Dec;124(3):835-44. doi: 10.1007/s10549-010-0912-1. Epub 2010 May 6.

19.

Change in lifestyle behaviors and medication use after a diagnosis of ductal carcinoma in situ.

Sprague BL, Trentham-Dietz A, Nichols HB, Hampton JM, Newcomb PA.

Breast Cancer Res Treat. 2010 Nov;124(2):487-95. doi: 10.1007/s10549-010-0869-0. Epub 2010 Apr 2.

20.

Accuracy of perceived risk of recurrence among patients with early-stage breast cancer.

Liu Y, Pérez M, Aft RL, Massman K, Robinson E, Myles S, Schootman M, Gillanders WE, Jeffe DB.

Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):675-80. doi: 10.1158/1055-9965.EPI-09-1051. Epub 2010 Feb 16. Erratum in: Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1661.

Supplemental Content

Support Center